Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SZSE: 002566)
Health Care · Pharmaceuticals · CN
CN¥6.79
+3.35% today · -18.2% 1Y
Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SZSE: 002566) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $334.28M and employs 1,656 people.
Over the last twelve months the share price has lost 18.2%, trading between 5.76 and 9.68.
Tweenvest scores Jilin Jian Yisheng Pharmaceutical Co., Ltd. across four factors: quality 76/100, value 34/100, growth 8/100, dividend 21/100. Its strongest factor is quality.
002566 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $334.28M
- Revenue (TTM)
- $95.64M
- P/E
- 67.51
- EPS
- 0.10
- Dividend yield
- 1.18%
- Beta (5Y)
- 0.14
- 52-week high
- CN¥9.68
- 52-week low
- CN¥5.76
- Avg volume (3M)
- —
- Shares outstanding
- 330.95M
- Employees
- 1,656
- Next earnings
- —
About Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Jilin Jian Yisheng Pharmaceutical Co., Ltd. is an enterprise based in Ji'an, China, established in 1997. The company specializes in the production and distribution of a diverse array of goods across the Chinese market. Its offerings include various pharmaceutical products, traditional Chinese herbal medicines, cosmetic items, and food products. Within its medical and health divisions, the firm provides goods in formats such as capsules, injections, tablets, and granules, with a particular emphasis on specialized medicinal products derived from Ginseng, as well as a selection of bee-related products.
- ISIN
- CNE1000011C3
- Founded
- 1997
- Listed since
- Mar 18, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.